GlobeNewswire 12/9/2023 Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...
GlobeNewswire 12/7/2023 Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at A...
GlobeNewswire 12/7/2023 Business Update
GlobeNewswire 11/6/2023 Vaxcyte Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire 11/1/2023 Dr. Hartmut Tintrup joins Cellbox Solutions GmbH as new CEO
GlobeNewswire 10/19/2023 Viralgen welcomes back Andy Holt as CCO
GlobeNewswire 10/16/2023 Vaxcyte and Lonza Expand Collaboration for Global Commercial Manufacturing of Broad-Spectrum Pneumoc...
GlobeNewswire 10/2/2023 Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
GlobeNewswire 9/20/2023 Oxford Biomedica Plc - INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2023
GlobeNewswire 9/19/2023 Galapagos appoints Simon Sturge to its Board of Directors
GlobeNewswire 9/13/2023 Culture Biosciences Appoints Darcy Birse as Chief Commercial Officer
GlobeNewswire 9/7/2023 Institutional Investor Launches 2023 Developed Europe & Emerging Emea Executive Team Rankings
GlobeNewswire 9/5/2023 Ascendis Pharma Reports Second Quarter 2023 Financial Results
GlobeNewswire 3/14/2022  aTyr Pharma Announces Fourth Quarter and Full Year 2021 Results and Provides Corporate Update
GlobeNewswire 2/10/2022 Finch Therapeutics Announces Additions to Senior Leadership Team
GlobeNewswire 1/4/2022 Kamran Tahamtanzadeh Joins Inanovate, Inc. as New Chief Executive Officer
GlobeNewswire 11/4/2021 Codiak BioSciences Reports Third Quarter 2021 Financial Results and Recent Operational Progress
GlobeNewswire 11/2/2021 Lonza to Acquire Codiak BioSciences Exosomes Manufacturing Facility and Establish a Long-Term Strate...
GlobeNewswire 10/12/2021 Moderna, VIA and Benchling Receive “Tell Awards” for FDI in Switzerland
GlobeNewswire 10/6/2021 Recro Reports Inducement Grants For New Staff
GlobeNewswire 9/24/2021 Capricor Therapeutics Announces Positive Final Data From its Phase 2 HOPE-2 Trial in Patients with D...
GlobeNewswire 9/8/2021 Affinia Therapeutics Announces Indications for Lead Gene Therapy Programs to Advance the Treatment o...
GlobeNewswire 8/24/2021 Vertex and Arbor Biotechnologies Establish New Partnership to Develop Novel ex vivo Engineered Cell ...
GlobeNewswire 8/17/2021 Gracell Biotechnologies Reports Second Quarter 2021 Unaudited Financial Results and Provides Corpora...
GlobeNewswire 8/11/2021 Vaxcyte Reports Second Quarter 2021 Financial Results and Provides Business Update